New-Onset Diabetes and Pancreatic Cancer

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 11, 2006, Pages 1366-1372

  Gupta, Samir ^a   Vittinghoff, Eric ^a   Bertenthal, Daniel ^b   Corley, Douglas ^c   Shen, Hui ^a   Walter, Louise C ^d   McQuaid, Kenneth ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Research Enhancement Award Program   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CHRONOLOGY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED STUDY; DATA BASE; DEFECATION HABIT; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIGASTRIC PAIN; EVALUATION; FEMALE; GASTROINTESTINAL SYMPTOM; GENDER; GROUPS BY AGE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PANCREAS CANCER; PATIENT CARE; RACE; RETROSPECTIVE STUDY; UNITED STATES; VETERAN;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS; TIME FACTORS; UNITED STATES; VETERANS;

EID: 33751214213     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.06.024     Document Type: Article

References (44)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Wagner M., Redaelli C., Lietz M., et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91 (2004) 586-594
3. Noy A., and Bilezikian J.P. Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab 79 (1994) 1223-1231
4. Morris D.V., and Nabarro J.D. Pancreatic cancer and diabetes mellitus. Diabet Med 1 (1984) 119-121
5. Calle E.E., Murphy T.K., Rodriguez C., et al. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 9 (1998) 403-410
6. Ragozzino M., Melton III L.J., Chu C.P., et al. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35 (1982) 13-19
7. Bonelli L., Aste H., Bovo P., et al. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy. Pancreas 27 (2003) 143-149
8. Frye J.N., Inder W.J., Dobbs B.R., et al. Pancreatic cancer and diabetes: is there a relationship?. A case-controlled study. Aust N Z J Surg 70 (2000) 722-724
9. Shibata A., Mack T.M., Paganini-Hill A., et al. A prospective study of pancreatic cancer in the elderly. Int J Cancer 58 (1994) 46-49
10. Smith G.D., Egger M., Shipley M.J., et al. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 136 (1992) 1110-1114
11. Cuzick J., and Babiker A.G. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer 43 (1989) 415-421
12. Stolzenber-Solomon R.Z., Pietinen P., Taylor P.R., et al. A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 13 (2002) 417-426
13. Kalapothaki V., Tzonou A., Hsieh C.C., et al. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control 4 (1993) 375-382
14. Everhart J., and Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273 (1995) 1605-1609
15. Chow W.H., Gridley G., Nyren O., et al. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst 87 (1995) 930-931
16. Gullo L., Pezzilli R., Morselli-Labate A.M., and Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. N Engl J Med 331 (1994) 81-84
17. Lin Y., Tamakoshi A., Kawamura T., et al. Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: findings from the Japan collaborative cohort study for evaluation of cancer risk. Int J Cancer 99 (2002) 742-746
18. Coughlin S.S., Calle E.E., Patel A.V., et al. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11 (2000) 915-923
19. Gapstur S.M., Gann P.H., Lowe W., et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283 (2000) 2552-2558
20. Kim T.D., Oh H.J., Kim K.H., et al. [Clinical characteristics of pancreatic cancer according to the presence of diabetes mellitus]. Korean J Gastroenterol 43 (2004) 35-40
21. Cetin M., Colak R., Bayram F., et al. High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey. Diabetes Res Clin Pract 58 (2002) 97-100
22. Permert J., Ihse I., Jorfeldt L., et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159 (1993) 101-107
23. Huxley R., Ansary-Moghaddam A., Berrington de Gonzalez A., et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92 (2005) 2076-2083
24. Saruc M., and Pour P.M. Diabetes and its relationship to pancreatic carcinoma. Pancreas 26 (2003) 381-387
25. Chari S.T., Leibson C.L., Rabe K.G., et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129 (2005) 504-511
26. Ogawa Y., Tanaka M., Inoue K., et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer 94 (2002) 2344-2349
27. Damiano J., Bordier L., Le Berre J.P., et al. Should pancreas imaging be recommended in patients over 50 years when diabetes is discovered because of acute symptoms?. Diabetes Metab 30 (2004) 203-207
28. VIReC Research User Guide: FY2002 VHA Medical SAS Outpatient Datasets. Hines, IL: Edward J. Hines, Jr. VA Hospital Veterans Affairs Information Resource Center, 2003. Available at http://www.virec.research.va.gov.
29. VIReC Research User Guide: FY2002 VHA Medical SAS Inpatient Datasets. Hines, IL: Edward J. Hines, Jr. VA Hospital Veterans Affairs Information Resource Center, 2003. Available at http://www.virec.research.va.gov.
30. Miller D.R., Safford M.M., and Pogach L.M. Who has diabetes?. Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 27 Suppl 2 (2004) B10-B21
31. McCullagh P., and Nelder J. Generalized linear models (1989), CRC Press, Boca Raton
32. Pepe M.S., and Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?. Stat Med 12 (1993) 737-751
33. Cox D., Oakes D., et al. Analysis of survival data (1984), Chapman and Hall, London
34. Permert J., Adrian T.E., Jacobsson P., et al. Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?. Am J Surg 165 (1993) 61-67
35. Fogar P., Basso D., Panozzo M.P., et al. C-peptide pattern in patients with pancreatic cancer. Anticancer Res 13 (1993) 2577-2580
36. Ahren B., and Andren-Sandberg A. Capacity to secrete islet hormones after subtotal pancreatectomy for pancreatic cancer. Eur J Surg 159 (1993) 223-227
37. Nakamori S., Ishikawa O., Ohigashi H., et al. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer. Hepatogastroenterology 46 (1999) 16-24
38. Ahren B., and Andren-Sandberg A. Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster. Res Exp Med (Berl) 193 (1993) 21-26
39. Permert J., Herrington M., Kazakoff K., et al. Early changes in islet hormone secretion in the hamster pancreatic cancer model. Teratog Carcinog Mutagen 21 (2001) 59-67
40. Permert J., Ihse I., Jorfeldt L., et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 80 (1993) 1047-1050
41. Holly E.A., Chaliha I., Bracci P.M., et al. Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area. Clin Gastroenterol Hepatol 2 (2004) 510-517
42. Permert J., Larsson J., Westermark G.T., et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 330 (1994) 313-318
43. Basso D., Greco E., Fogar P., et al. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications. Clin Chim Acta 357 (2005) 184-189
44. Kashner T.M. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care 36 (1998) 1324-1336